Retinoic acid and arsenic for treating acute promyelocytic leukemia.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15696202.
- Also identified by PMC identifier 545204.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
What were the critical steps in the development of ATRA and arsenic as treatments for APL? Researchers in Shanghai tell the story and look to the future
Medical subject headings
- Antineoplastic Agents
- Arsenic
- Leukemia, Promyelocytic, Acute
- Tretinoin